𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-Term Therapy of Chronic Hepatitis B With Lamivudine

✍ Scribed by Daryl T Lau; M Farooq Khokhar; Edward Doo; Marc G Ghany; David Herion; Yoon Park; David E Kleiner; Peter Schmid; Lynn D Condreay; Josée Gauthier; Mary C Kuhns; T Jake Liang; Jay H Hoofnagle

Book ID
111721157
Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
259 KB
Volume
32
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of hepatitis B e antigen–negativ
Outcome of hepatitis B e antigen–negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
✍ George V. Papatheodoridis; Evangelini Dimou; Konstantinos Dimakopoulos; Spilios 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 1 views

We determined the clinical outcome of hepatitis e antigen (HBeAg)-negative chronic hepatitis B patients treated with long-term nucleos(t)ide analog therapy starting with lamivudine. We evaluated 201 such patients treated for 3.8 ؎ 1.4 years and 2 historical similar cohorts: 1 treated with interferon

Favorable efficacy of long-term lamivudi
Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: An 8-year follow-up study
✍ Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Hitomi Sezaki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract The long‐term efficacy of lamivudine therapy in patients with hepatitis B virus (HBV) infection is still not clear. In this study, 20 non‐cirrhotic Japanese patients infected with HBV received lamivudine therapy for more than 1 year and were followed for a median period of 8.5 years (ra

Long-term lamivudine therapy for childre
Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B
✍ Etienne M. Sokal; Deirdre A. Kelly; Jacek Mizerski; Isabel B. Badia; Jorge A. Ar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

One year of lamivudine treatment results in increased hepatitis B e antigen (HBeAg) seroconversion and serum hepatitis B virus (HBV) DNA negativity in children with chronic hepatitis B and high serum alanine aminotransferase concentrations. Two hundred seventy-six children who participated in a 1-ye